Fig. 6From: Somatic mutation of DNAH genes implicated higher chemotherapy response rate in gastric adenocarcinoma patientsKaplan–Meier analyses of overall survival, progression-free survival, and chemotherapy-free survival in patients stratified by mutation frequency. The patients with gastric cancer tumors were dichotomously categorized based on mutation rate into the following two groups: high (highest one-third, n = 44) and low (bottom two-thirds, n = 88) mutation frequency. Subgroups were compared via the log-rank testBack to article page